Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 7.0B | 6.2B | 6.5B | 6.1B |
Cost of revenue | 4.3B | 3.8B | 3.9B | 3.7B |
Gross profit | 2.7B | 2.5B | 2.6B | 2.4B |
Operating expense | ||||
Research & development | 198M | 174M | 200M | 187M |
Selling general and admin | 1.6B | 1.4B | 1.5B | 1.5B |
Other operating expenses | 61M | 203M | 8M | 23M |
Operating income | 936M | 705M | 923M | 818M |
Non operating interest income | ||||
Income | 121M | -46M | 4M | 114M |
Expense | 101M | 185M | 98M | 103M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 1.3B | 1.9B | 2.2B |
Tax provision | 226M | 222M | 197M | 160M |
Net income | 1.5B | 1.1B | 1.7B | 2.0B |
Basic EPS | 2.3 | 1.7 | 2.6 | 3.1 |
Diluted EPS | 2.3 | 1.7 | 2.6 | 3.1 |
Basic average shares | 6.2B | 6.2B | 6.2B | 6.2B |
Diluted average shares | 6.2B | 6.2B | 6.2B | 6.2B |
EBITDA | 1.8B | 1.5B | 2.0B | 2.3B |
Net income from continuing op. | 944M | — | — | — |
Minority interests | -2M | -9M | -11M | -8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |